These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 37460823)

  • 21. Associations of Systolic Blood Pressure With Incident CKD G3-G5: A Cohort Study of South Korean Adults.
    Chang TI; Lim H; Park CH; Rhee CM; Moradi H; Kalantar-Zadeh K; Kang EW; Kang SW; Han SH
    Am J Kidney Dis; 2020 Aug; 76(2):224-232. PubMed ID: 32305207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial.
    Heerspink HJL; Jongs N; Chertow GM; Langkilde AM; McMurray JJV; Correa-Rotter R; Rossing P; Sjöström CD; Stefansson BV; Toto RD; Wheeler DC; Greene T;
    Lancet Diabetes Endocrinol; 2021 Nov; 9(11):743-754. PubMed ID: 34619108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of achieved blood pressure after treatment for primary aldosteronism with long-term kidney function.
    Haze T; Yano Y; Hatano Y; Tamura K; Kurihara I; Kobayashi H; Tsuiki M; Ichijo T; Wada N; Katabami T; Yamamoto K; Okamura S; Kai T; Izawa S; Yoshikawa Y; Yamada M; Chiba Y; Tanabe A; Naruse M;
    J Hum Hypertens; 2022 Oct; 36(10):904-910. PubMed ID: 34462544
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Blood pressure components and decline in kidney function in community-living older adults: the Cardiovascular Health Study.
    Rifkin DE; Katz R; Chonchol M; Shlipak MG; Sarnak MJ; Fried LF; Newman AB; Siscovick DS; Peralta CA
    Am J Hypertens; 2013 Aug; 26(8):1037-44. PubMed ID: 23709568
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Visit-to-visit variability in blood pressure and the development of chronic kidney disease in treated general hypertensive patients.
    Li Y; Li D; Song Y; Gao L; Fan F; Wang B; Liang M; Wang G; Li J; Zhang Y; Xu X; Hou FF; Cheng X; Sun N; Sun Y; Zhao L; Wan Q; Li X; Li J; Han Q; Xu X; Huo Y; Qin X
    Nephrol Dial Transplant; 2020 Oct; 35(10):1739-1746. PubMed ID: 31102525
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Blood pressure and renal function decline: a 7-year prospective cohort study in middle-aged rural Chinese men and women.
    Wang Q; Xie D; Xu X; Qin X; Tang G; Wang B; Wang Y; Hou F; Xu X; Wang X
    J Hypertens; 2015 Jan; 33(1):136-43. PubMed ID: 25255396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes in Blood Pressure During Young Adulthood and Subsequent Kidney Function Decline: Findings From the Coronary Artery Risk Development in Young Adulthood (CARDIA) Study.
    Ku E; Vittinghoff E; Jacobs DR; Lewis CE; Allen NB; Bibbins-Domingo K; Shlipak M; Kramer H; Peralta CA
    Am J Kidney Dis; 2018 Aug; 72(2):243-250. PubMed ID: 29510922
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age and Outcomes Associated with BP in Patients with Incident CKD.
    Kovesdy CP; Alrifai A; Gosmanova EO; Lu JL; Canada RB; Wall BM; Hung AM; Molnar MZ; Kalantar-Zadeh K
    Clin J Am Soc Nephrol; 2016 May; 11(5):821-831. PubMed ID: 27103623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic significance of home blood pressure control on renal and cardiovascular outcomes in elderly patients with chronic kidney disease.
    Okada T; Nakao T; Matsumoto H; Nagaoka Y; Tomaru R; Iwasawa H; Wada T
    Hypertens Res; 2009 Dec; 32(12):1123-9. PubMed ID: 19816503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Slope of Kidney Function and Its Association with Longitudinal Mortality and Cardiovascular Disease among Individuals with CKD.
    Orlandi PF; Xie D; Yang W; Cohen JB; Deo R; Ricardo AC; Schrauben S; Wang X; Hamm LL; He J; Sondheimer JH; Kallem K; Townsend R; Raj D; Parsa A; Anderson AH; Feldman HI; ;
    J Am Soc Nephrol; 2020 Dec; 31(12):2912-2923. PubMed ID: 33023926
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood pressure and risk of all-cause mortality in advanced chronic kidney disease and hemodialysis: the chronic renal insufficiency cohort study.
    Bansal N; McCulloch CE; Rahman M; Kusek JW; Anderson AH; Xie D; Townsend RR; Lora CM; Wright J; Go AS; Ojo A; Alper A; Lustigova E; Cuevas M; Kallem R; Hsu CY;
    Hypertension; 2015 Jan; 65(1):93-100. PubMed ID: 25287404
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Modifying Effect of Statins on Fatal Outcomes in Chronic Kidney Disease Patients in the Systolic Blood Pressure Intervention Trial: A Post Hoc Analysis.
    Rivera M; Tamariz L; Suarez M; Contreras G
    Am J Nephrol; 2019; 49(4):297-306. PubMed ID: 30917364
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness and Tolerability of Nifedipine GITS in Patients with Chronic Kidney Disease and Uncontrolled Hypertension: A Prospective, Multicenter, Observational Study (ADRENAL).
    Lv R; Chen J; Wang H; Wang J; Cheng H; Li R; Li W; Zhang T; Wei L; Chen Q; Huang J; Yu F; Shen S; Wu H; Liu C; Hong F; Liu J; Zhang X; Xiao H; Song W
    Adv Ther; 2021 Sep; 38(9):4771-4785. PubMed ID: 34331258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Short-term Blood Pressure Variability and Incident CKD in Patients With Hypertension: Findings From the Cardiovascular and Metabolic Disease Etiology Research Center-High Risk (CMERC-HI) Study.
    Jhee JH; Oh D; Seo J; Lee CJ; Chung MY; Park JT; Han SH; Kang SW; Park S; Yoo TH
    Am J Kidney Dis; 2023 Apr; 81(4):384-393.e1. PubMed ID: 36241008
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ambulatory blood pressure variability and risk of cardiovascular events, all-cause mortality, and progression of kidney disease.
    Jhee JH; Seo J; Lee CJ; Park JT; Han SH; Kang SW; Park S; Yoo TH
    J Hypertens; 2020 Sep; 38(9):1712-1721. PubMed ID: 32516289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of Intensive Systolic Blood Pressure Control on Kidney and Cardiovascular Outcomes in Persons Without Kidney Disease: A Secondary Analysis of a Randomized Trial.
    Beddhu S; Rocco MV; Toto R; Craven TE; Greene T; Bhatt U; Cheung AK; Cohen D; Freedman BI; Hawfield AT; Killeen AA; Kimmel PL; Lash J; Papademetriou V; Rahman M; Rastogi A; Servilla K; Townsend RR; Wall B; Whelton PK;
    Ann Intern Med; 2017 Sep; 167(6):375-383. PubMed ID: 28869987
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Systolic inter-arm blood pressure difference and estimated glomerular filtration rate in type 2 diabetic patients in Palestine: a cross-sectional study.
    Sweity R; Fanoun K; Jarrar T; Alqtishat BF; Abdelhafez M; Ereqat S
    Ann Med; 2023; 55(2):2259927. PubMed ID: 37748114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association between hemoglobin and chronic kidney disease progression: a secondary analysis of a prospective cohort study in Japanese patients.
    Pan W; Han Y; Hu H; He Y
    BMC Nephrol; 2022 Aug; 23(1):295. PubMed ID: 35999502
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sex Differences in the Progression of CKD Among Older Patients: Pooled Analysis of 4 Cohort Studies.
    Minutolo R; Gabbai FB; Chiodini P; Provenzano M; Borrelli S; Garofalo C; Bellizzi V; Russo D; Conte G; De Nicola L;
    Am J Kidney Dis; 2020 Jan; 75(1):30-38. PubMed ID: 31409508
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Blood pressure and antihypertensive medication profile in a multiethnic Asian population of stable chronic kidney disease patients.
    Teo BW; Chua HR; Wong WK; Haroon S; Subramanian S; Loh PT; Sethi S; Lau T
    Singapore Med J; 2016 May; 57(5):267-73. PubMed ID: 27212015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.